Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S27 pseudogene 19 (RPS27P19) is a pseudogene in the human genome, related to the functional gene encoding ribosomal protein S27. Pseudogenes like RPS27P19 typically do not encode functional proteins and are not considered active drug targets. RPS27P19 shares similarity with the parent RPS27 gene but lacks known biological function and clinical relevance as a therapeutic target[1][4][5][6]. Notes on correctness and interpretation: - RPS27P19 is not a functional protein-coding gene but a pseudogene, differentiating it from ribosomal protein S27 (RPS27), which is an active ribosomal component involved in translation and cellular stress responses[1][4][5][6]. - There is no evidence of RPS27P19 acting as a therapeutic target, participating in biological pathways, or involvement in disease as a biomarker or mechanism. - Therefore, RPS27P19 should not be considered a conventional molecular target for drug discovery or biological studies. If a functional or therapeutic target is intended, the correct entry would be "Ribosomal protein S27" (RPS27) and not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S27 pseudogene 19 (RPS27P19).